Display options
Cite
Kumai T, Matsuda Y, Ohkuri T, et al. c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma. Oncoimmunology. 2015;4(2):e976077doi: 10.4161/2162402X.2014.976077.
Kumai, T., Matsuda, Y., Ohkuri, T., Oikawa, K., Ishibashi, K., Aoki, N., Kimura, S., Harabuchi, Y., Celis, E., & Kobayashi, H. (2015). c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma. Oncoimmunology, 4(2), e976077. https://doi.org/10.4161/2162402X.2014.976077
Kumai, Takumi, et al. "c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma." Oncoimmunology vol. 4,2 (2015): e976077. doi: https://doi.org/10.4161/2162402X.2014.976077
Kumai T, Matsuda Y, Ohkuri T, Oikawa K, Ishibashi K, Aoki N, Kimura S, Harabuchi Y, Celis E, Kobayashi H. c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma. Oncoimmunology. 2015 Mar 06;4(2):e976077. doi: 10.4161/2162402X.2014.976077. eCollection 2015 Feb. PMID: 25949874; PMCID: PMC4404796.
Copy Download .nbib Format: NLM
Share it on

Oncoimmunology. 2015 Mar 06;4(2):e976077. doi: 10.4161/2162402X.2014.976077. eCollection 2015 Feb.

c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma.

Oncoimmunology

Takumi Kumai, Yoshinari Matsuda, Takayuki Ohkuri, Kensuke Oikawa, Kei Ishibashi, Naoko Aoki, Shoji Kimura, Yasuaki Harabuchi, Esteban Celis, Hiroya Kobayashi

Affiliations

  1. Department of Pathology; Asahikawa Medical University ; Asahikawa, Japan ; Department of Otolaryngology; Head and Neck Surgery; Asahikawa Medical University ; Asahikawa, Japan ; Cancer Immunology; Inflammation and Tolerance Program; Georgia Regents University Cancer Center ; Augusta, GA USA.
  2. Department of Pathology; Asahikawa Medical University ; Asahikawa, Japan.
  3. Department of Otolaryngology; Head and Neck Surgery; Asahikawa Medical University ; Asahikawa, Japan.
  4. Cancer Immunology; Inflammation and Tolerance Program; Georgia Regents University Cancer Center ; Augusta, GA USA.

PMID: 25949874 PMCID: PMC4404796 DOI: 10.4161/2162402X.2014.976077

[No abstract available.]

Keywords: APCs, antigen presenting cells; CD4+ helper T lymphocytes; DC, dendritic cell; EBV, Epstein-Barr virus; HNSCC, head and neck squamous cell carcinoma; HPLC, high-performance liquid chromatography; HSP, heat shock protein; HTLs, helper CD4+ T cells; L-cell, mouse fibroblast cell line; LDH, lactate dehydrogenase; NK/T cell lymphoma; NKTCL, natural killer/ T cell lymphoma; PBMC, peripheral blood mononuclear cell; PBS, phosphate buffered saline; TCR, T cell receptor; TGF-β; TKI, tyrosine kinase receptor inhibitor; autophagy; c-Met; head and neck squamous cell carcinoma; immunotherapy; major histocompatibility complex class II; tumor antigens

References

  1. Cancer Immunol Immunother. 2014 May;63(5):469-78 - PubMed
  2. Cancer Res. 2008 Sep 1;68(17):6889-95 - PubMed
  3. Blood. 2001 Feb 1;97(3):708-13 - PubMed
  4. Invest New Drugs. 2014 Apr;32(2):355-61 - PubMed
  5. Clin Cancer Res. 2013 Mar 15;19(6):1476-86 - PubMed
  6. PLoS One. 2013 May 03;8(5):e63566 - PubMed
  7. Clin Cancer Res. 2008 Feb 1;14(3):797-803 - PubMed
  8. Cancer Sci. 2012 Feb;103(2):375-81 - PubMed
  9. J Exp Med. 2003 Dec 15;198(12):1875-86 - PubMed
  10. J Transl Med. 2011 Nov 05;9:191 - PubMed
  11. Cancer. 1996 May 15;77(10):2137-49 - PubMed
  12. J Transl Med. 2014 Sep 21;12:265 - PubMed
  13. Clin Cancer Res. 2004 Jun 1;10(11):3658-66 - PubMed
  14. Mol Cancer Ther. 2011 Sep;10(9):1533-41 - PubMed
  15. Clin Cancer Res. 2002 Feb;8(2):620-7 - PubMed
  16. Clin Cancer Res. 2009 Jun 1;15(11):3740-50 - PubMed
  17. J Clin Oncol. 2011 Nov 20;29(33):4410-6 - PubMed
  18. Clin Cancer Res. 2014 Feb 15;20(4):938-50 - PubMed
  19. Leukemia. 2003 Apr;17 (4):764-74 - PubMed
  20. Clin Cancer Res. 2012 Dec 1;18(23):6485-96 - PubMed
  21. Am J Pathol. 1992 Apr;140(4):769-74 - PubMed
  22. Clin Cancer Res. 2004 Jan 15;10(2):634-40 - PubMed
  23. Clin Exp Immunol. 1999 Mar;115(3):385-92 - PubMed
  24. J Clin Oncol. 2012 Sep 10;30(26):3287-96 - PubMed
  25. J Immunol. 1998 Apr 1;160(7):3363-73 - PubMed
  26. Clin Cancer Res. 2013 Feb 1;19(3):571-85 - PubMed
  27. J Leukoc Biol. 2009 Jun;85(6):905-10 - PubMed
  28. Cancer Res. 2013 Dec 1;73(23):7022-33 - PubMed
  29. Immunity. 2013 Jul 25;39(1):1-10 - PubMed
  30. Br J Haematol. 1997 Jun;97(4):821-9 - PubMed

Publication Types